Long Terminal Repeat CRISPR-CAR-Coupled “Universal” T Cells Mediate Potent Anti-leukemic Effects

Rivière, 2017, Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective, Mol. Ther., 25, 1117, 10.1016/j.ymthe.2017.03.034 Torikai, 2012, A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR, Blood, 119, 5697, 10.1182/blood-2012-01-405365 Provasi, 2012, Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer, Nat. Med., 18, 807, 10.1038/nm.2700 Qasim, 2017, Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells, Sci. Transl. Med., 9, 10.1126/scitranslmed.aaj2013 Poirot, 2015, Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies, Cancer Res., 75, 3853, 10.1158/0008-5472.CAN-14-3321 Bertaina, 2014, HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders, Blood, 124, 822, 10.1182/blood-2014-03-563817 Osborn, 2016, Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases, Mol. Ther., 24, 570, 10.1038/mt.2015.197 Ren, 2017, A versatile system for rapid multiplex genome-edited CAR T cell generation, Oncotarget, 8, 17002, 10.18632/oncotarget.15218 Ren, 2016, Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition, Clin. Cancer Res., 23, 2255, 10.1158/1078-0432.CCR-16-1300 Shalem, 2014, Genome-scale CRISPR-Cas9 knockout screening in human cells, Science, 343, 84, 10.1126/science.1247005 Adam, 1995, R-region cDNA inserts in retroviral vectors are compatible with virus replication and high-level protein synthesis from the insert, Hum. Gene Ther., 6, 1169, 10.1089/hum.1995.6.9-1169 Szulc, 2006, A versatile tool for conditional gene expression and knockdown, Nat. Methods, 3, 109, 10.1038/nmeth846 Curtin, 2008, Bidirectional promoter interference between two widely used internal heterologous promoters in a late-generation lentiviral construct, Gene Ther., 15, 384, 10.1038/sj.gt.3303105 Hsu, 2014, Development and applications of CRISPR-Cas9 for genome engineering, Cell, 157, 1262, 10.1016/j.cell.2014.05.010 Kleinstiver, 2016, High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects, Nature, 529, 490, 10.1038/nature16526 Tycko, 2016, Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity, Mol. Cell, 63, 355, 10.1016/j.molcel.2016.07.004 Kim, 2015, Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells, Nat. Methods, 12, 237, 10.1038/nmeth.3284 Tsai, 2015, GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases, Nat. Biotechnol., 33, 187, 10.1038/nbt.3117 Knipping, 2017, Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor Modification, Mol. Ther. Methods Clin. Dev., 4, 213, 10.1016/j.omtm.2017.01.005 Jacoby, 2016, Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD, Blood, 127, 1361, 10.1182/blood-2015-08-664250 Ghosh, 2017, Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity, Nat. Med., 23, 242, 10.1038/nm.4258 Newrzela, 2008, Resistance of mature T cells to oncogene transformation, Blood, 112, 2278, 10.1182/blood-2007-12-128751 Ran, 2015, In vivo genome editing using Staphylococcus aureus Cas9, Nature, 520, 186, 10.1038/nature14299 Zetsche, 2015, Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system, Cell, 163, 759, 10.1016/j.cell.2015.09.038 Fonfara, 2016, The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA, Nature, 532, 517, 10.1038/nature17945 Ran, 2013, Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity, Cell, 154, 1380, 10.1016/j.cell.2013.08.021 Maeder, 2013, CRISPR RNA-guided activation of endogenous human genes, Nat. Methods, 10, 977, 10.1038/nmeth.2598 Perez-Pinera, 2013, RNA-guided gene activation by CRISPR-Cas9-based transcription factors, Nat. Methods, 10, 973, 10.1038/nmeth.2600 Komor, 2016, Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage, Nature, 533, 420, 10.1038/nature17946 Eyquem, 2017, Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection, Nature, 543, 113, 10.1038/nature21405 Dull, 1998, A third-generation lentivirus vector with a conditional packaging system, J. Virol., 72, 8463, 10.1128/JVI.72.11.8463-8471.1998 Demaison, 2002, High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of immunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter, Hum. Gene Ther., 13, 803, 10.1089/10430340252898984 Qasim, 2007, Lentiviral vectors for T-cell suicide gene therapy: preservation of T-cell effector function after cytokine-mediated transduction, Mol. Ther., 15, 355, 10.1038/sj.mt.6300042 Mock, 2016, Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigy, Cytotherapy, 18, 1002, 10.1016/j.jcyt.2016.05.009 Brinkman, 2014, Easy quantitative assessment of genome editing by sequence trace decomposition, Nucleic Acids Res., 42, e168, 10.1093/nar/gku936 Kim, 2016, Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq, Genome Res., 26, 406, 10.1101/gr.199588.115